2-[2-[5-[[2-(2,5-dimethylphenoxy)acetyl]amino]pentyl]benzimidazol-1-yl]-N-phenyl-N-propan-2-ylacetamide

C33H40N4O3 — CID 16993131

IUPAC2-[2-[5-[[2-(2,5-dimethylphenoxy)acetyl]amino]pentyl]benzimidazol-1-yl]-N-phenyl-N-propan-2-ylacetamide
SMILESCc1ccc(C)c(OCC(=O)NCCCCCc2nc3ccccc3n2CC(=O)N(c2ccccc2)C(C)C)c1
InChIInChI=1S/C33H40N4O3/c1-24(2)37(27-13-7-5-8-14-27)33(39)22-36-29-16-11-10-15-28(29)35-31(36)17-9-6-12-20-34-32(38)23-40-30-21-25(3)18-19-26(30)4/h5,7-8,10-11,13-16,18-19,21,24H,6,9,12,17,20,22-23H2,1-4H3,(H,34,38)
InChIKeyUDHKCEUZZKCWKW-UHFFFAOYSA-N
MW540.71 g/mol
LogP6.00
Rot. Bonds13

About 2-[2-[5-[[2-(2,5-dimethylphenoxy)acetyl]amino]pentyl]benzimidazol-1-yl]-N-phenyl-N-propan-2-ylacetamide

2-[2-[5-[[2-(2,5-dimethylphenoxy)acetyl]amino]pentyl]benzimidazol-1-yl]-N-phenyl-N-propan-2-ylacetamide (PubChem CID 16993131) has the molecular formula C33H40N4O3 and a molecular weight of 540.71 g/mol. Its IUPAC name is 2-[2-[5-[[2-(2,5-dimethylphenoxy)acetyl]amino]pentyl]benzimidazol-1-yl]-N-phenyl-N-propan-2-ylacetamide.

Molecular Properties

Compound Name2-[2-[5-[[2-(2,5-dimethylphenoxy)acetyl]amino]pentyl]benzimidazol-1-yl]-N-phenyl-N-propan-2-ylacetamide
PubChem CID16993131
Molecular FormulaC33H40N4O3
Molecular Weight540.71 g/mol
Exact Mass540.31
IUPAC Name2-[2-[5-[[2-(2,5-dimethylphenoxy)acetyl]amino]pentyl]benzimidazol-1-yl]-N-phenyl-N-propan-2-ylacetamide
SMILESCc1ccc(C)c(OCC(=O)NCCCCCc2nc3ccccc3n2CC(=O)N(c2ccccc2)C(C)C)c1
InChIInChI=1S/C33H40N4O3/c1-24(2)37(27-13-7-5-8-14-27)33(39)22-36-29-16-11-10-15-28(29)35-31(36)17-9-6-12-20-34-32(38)23-40-30-21-25(3)18-19-26(30)4/h5,7-8,10-11,13-16,18-19,21,24H,6,9,12,17,20,22-23H2,1-4H3,(H,34,38)
InChIKeyUDHKCEUZZKCWKW-UHFFFAOYSA-N
XLogP6.00
TPSA76.46 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds13
Heavy Atoms40
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500540.71
LogP ≤ 56.00
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 2-[2-[5-[[2-(2,5-dimethylphenoxy)acetyl]amino]pentyl]benzimidazol-1-yl]-N-phenyl-N-propan-2-ylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[2-[5-[[2-(2,5-dimethylphenoxy)acetyl]amino]pentyl]benzimidazol-1-yl]-N-phenyl-N-propan-2-ylacetamide?
The IUPAC name of 2-[2-[5-[[2-(2,5-dimethylphenoxy)acetyl]amino]pentyl]benzimidazol-1-yl]-N-phenyl-N-propan-2-ylacetamide (CID 16993131) is 2-[2-[5-[[2-(2,5-dimethylphenoxy)acetyl]amino]pentyl]benzimidazol-1-yl]-N-phenyl-N-propan-2-ylacetamide.
What is the SMILES notation for 2-[2-[5-[[2-(2,5-dimethylphenoxy)acetyl]amino]pentyl]benzimidazol-1-yl]-N-phenyl-N-propan-2-ylacetamide?
The canonical SMILES for 2-[2-[5-[[2-(2,5-dimethylphenoxy)acetyl]amino]pentyl]benzimidazol-1-yl]-N-phenyl-N-propan-2-ylacetamide is Cc1ccc(C)c(OCC(=O)NCCCCCc2nc3ccccc3n2CC(=O)N(c2ccccc2)C(C)C)c1.
What is the InChIKey of 2-[2-[5-[[2-(2,5-dimethylphenoxy)acetyl]amino]pentyl]benzimidazol-1-yl]-N-phenyl-N-propan-2-ylacetamide?
The InChIKey is UDHKCEUZZKCWKW-UHFFFAOYSA-N. The full InChI is InChI=1S/C33H40N4O3/c1-24(2)37(27-13-7-5-8-14-27)33(39)22-36-29-16-11-10-15-28(29)35-31(36)17-9-6-12-20-34-32(38)23-40-30-21-25(3)18-19-26(30)4/h5,7-8,10-11,13-16,18-19,21,24H,6,9,12,17,20,22-23H2,1-4H3,(H,34,38).
What are the key properties of 2-[2-[5-[[2-(2,5-dimethylphenoxy)acetyl]amino]pentyl]benzimidazol-1-yl]-N-phenyl-N-propan-2-ylacetamide?
2-[2-[5-[[2-(2,5-dimethylphenoxy)acetyl]amino]pentyl]benzimidazol-1-yl]-N-phenyl-N-propan-2-ylacetamide has a molecular weight of 540.71 g/mol, XLogP of 6.00, 13 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[2-[5-[[2-(2,5-dimethylphenoxy)acetyl]amino]pentyl]benzimidazol-1-yl]-N-phenyl-N-propan-2-ylacetamide is sourced from PubChem (CID 16993131), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).